Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30142% above fair value
$56.95+1.58 (+2.85%)
Close on Nov 18, 2026Market cap $3.40BP/E –Yield –
Axogen market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Axogen's market cap was $3.15B on Nov 11, 2026, against $1.32B a year earlier. Over the last 5 years it ranged from $161.60M to $3.15B, with a median of $481.18M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.15B | +108.4% |
| 2025 | Dec 31, 2025 | $1.51B | +108.2% |
| 2024 | Dec 31, 2024 | $725.16M | +146.7% |
| 2023 | Dec 29, 2023 | $293.96M | -30.3% |
| 2022 | Dec 30, 2022 | $421.88M | +8.3% |
| 2021 | Dec 31, 2021 | $389.41M | -45.8% |
| 2020 | Dec 31, 2020 | $718.22M | +1.7% |
| 2019 | Dec 31, 2019 | $705.96M | -10.6% |
| 2018 | Dec 31, 2018 | $790.07M | -16.4% |
| 2017 | Dec 29, 2017 | $945.04M | +247.6% |
| 2016 | Dec 30, 2016 | $271.88M | +82.2% |
| 2015 | Dec 31, 2015 | $149.22M | +138.0% |
| 2014 | Dec 31, 2014 | $62.70M | -19.5% |
| 2013 | Dec 31, 2013 | $77.85M | +160.7% |
| 2012 | Dec 31, 2012 | $29.87M | +1.0% |
| 2011 | Dec 30, 2011 | $29.56M | – |
See a number that looks wrong?